ArticleApplied biochemistry and biotechnology2022
A Novel Rhizospheric Bacterium: Bacillus velezensis NKMV-3 as a Biocontrol Agent Against Alternaria Leaf Blight in Tomato.
Article in Applied biochemistry and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Occurrence, toxicity, dietary exposure, and management of Alternaria mycotoxins in food and feed: A systematic literature review.Comprehensive reviews in food science and food safety · 2025Pooled it
- Differential Assembly of Rhizosphere Microbiome and Metabolome in Rice with Contrasting Resistance to Blast Disease.Microorganisms · 2025Article
- Bacillus velezensis ES2-4 modulates root exudation and microbiome remodeling to enhance soybean resistance against gray mold.Scientific reports · 2025Article
- Review
- Antimicrobial Activity ofInternational journal of molecular sciences · 2025Review
- Comparative Genomic Analysis ofGenes · 2024Article
- Genomic Insights into the Bactericidal and Fungicidal Potential ofMicroorganisms · 2024Article
- The RhizobacteriumMicroorganisms · 2024Article
- Analysis of antimicrobial biological activity of a marine Bacillus velezensis NDB.Archives of microbiology · 2024Article
- Endophytes and Plant Extracts as Potential Antimicrobial Agents againstMicroorganisms · 2023Article
- Effects ofToxins · 2023Article
- Antagonistic transcriptome profile reveals potential mechanisms of action onFrontiers in cellular and infection microbiology · 2023Article
- Soil nutrient management influences diversity, community association and functional structure of rhizosphere bacteriome under vegetable crop production.Frontiers in microbiology · 2023Article
- Bio-Prospecting of Endospore-Based Formulation of Bacillus sp. BST18 Possessing Antimicrobial Genes for the Management of Soil-Borne Diseases of Tomato.Current microbiology · 2022Article
- Biocontrol activity and action mechanism ofFrontiers in microbiology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A novel strain of Bacillus isolated from rhizosphere has shown to be an excellent biocontrol agent against various plant pathogens. In this study, a first report of a Bacillus strain NKMV-3 which effectively controls Alternaria solani, which cause the early blight disease in tomato. Based on the cultural and molecular sequencing of 16S rRNA gene sequence, the identity of the strain was confirmed as Bacillus velezensis NKMV-3. The presence of the lipopeptide which are antibiotic synthesis genes, namely iturin C, surfactin A and fengycin B and D, was confirmed through gene amplification. In addition, lipopeptides were also confirmed through liquid chromatography. The extract showed inhibitory effect against A. solani in vitro and detached tomato leaf assays. Bacillus velezensis strain NKMV-3-based formulations may provide an effective solution in controlling early blight disease in tomato and other crops.
Indexed as
Identifiers
34586599What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.